Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients
The timing of chemoradiotherapy did not play a prognostic role. For OS, the radiotherapy dose, and for PFS, MGMT-status and the number of adjuvant TMZ cycles were identified as independent prognostic factors.
Authors
- Larysa Liubich (ORCID: https://orcid.org/0000-0001-6382-3643)
- Jan Gliemroth
- Dirk Rades (ORCID: https://orcid.org/0000-0002-3221-7541)
- Maximilian Grohmann (ORCID: https://orcid.org/0000-0002-6909-811X)
- Jan Leppert (ORCID: https://orcid.org/0000-0001-8857-8103)
- Christian Ziemann (ORCID: https://orcid.org/0000-0003-1441-2383)
- Christina Hillbricht
- Claudia Ditz
- Anastassia Löser (ORCID: https://orcid.org/0000-0003-4981-7217)
- Maria Vittoria Matone
Institutions
- Universität Hamburg (DE)
- Universitäres Kinderwunschzentrum Lübeck (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- Romodanov Neurosurgery Institute of the National Academy of Medical Sciences of Ukraine (UA)
- University of Lübeck (DE)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.21873/anticanres.17269
- Citations
- 1
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.44
Funders
- Universität zu Lübeck